ENOV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ENOV.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ENOV had positive earnings in the past year.
ENOV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
ENOV had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -30.84%, ENOV perfoms like the industry average, outperforming 42.39% of the companies in the same industry.
ENOV's Return On Equity of -67.66% is in line compared to the rest of the industry. ENOV outperforms 45.65% of its industry peers.
ENOV has a better Return On Invested Capital (0.12%) than 64.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-30.84%
ROE	-67.66%
ROIC	0.12%

ROA(3y)-6.18%

ROA(5y)-3.42%

ROE(3y)-11.19%

ROE(5y)-6.16%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 0.25%, ENOV is in the better half of the industry, outperforming 64.67% of the companies in the same industry.
ENOV's Operating Margin has declined in the last couple of years.
The Gross Margin of ENOV (57.19%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ENOV has grown nicely.

		Industry Rank	Sector Rank
OM	0.25%
PM (TTM)	N/A
GM	57.19%

OM growth 3YN/A

OM growth 5Y-43.59%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.41%

GM growth 5Y6.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
Compared to 1 year ago, ENOV has more shares outstanding
ENOV has more shares outstanding than it did 5 years ago.
ENOV has a worse debt/assets ratio than last year.

2.2 Solvency

ENOV has an Altman-Z score of 0.72. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
ENOV's Altman-Z score of 0.72 is in line compared to the rest of the industry. ENOV outperforms 48.91% of its industry peers.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
ENOV's Debt to FCF ratio of 59.72 is fine compared to the rest of the industry. ENOV outperforms 66.85% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, ENOV is doing worse than 64.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	59.72
Altman-Z	0.72

ROIC/WACC0.01

WACC9.68%

2.3 Liquidity

ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
ENOV has a Current ratio (2.22) which is comparable to the rest of the industry.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
ENOV has a Quick ratio of 1.16. This is in the lower half of the industry: ENOV underperforms 69.02% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.22
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.

EPS 1Y (TTM)26.14%

EPS 3Y-23.78%

EPS 5Y-16.18%

EPS Q2Q%2.74%

Revenue 1Y (TTM)11.57%

Revenue growth 3Y13.9%

Revenue growth 5Y-8.73%

Sales Q2Q%8.65%

3.2 Future

Based on estimates for the next years, ENOV will show a very strong growth in Earnings Per Share. The EPS will grow by 23.19% on average per year.
ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.87% yearly.

EPS Next Y14.57%

EPS Next 2Y11.17%

EPS Next 3Y11.67%

EPS Next 5Y23.19%

Revenue Next Year7.37%

Revenue Next 2Y5.98%

Revenue Next 3Y6.01%

Revenue Next 5Y8.87%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.62, the valuation of ENOV can be described as very cheap.
98.37% of the companies in the same industry are more expensive than ENOV, based on the Price/Earnings ratio.
ENOV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.30.
With a Price/Forward Earnings ratio of 6.30, the valuation of ENOV can be described as very cheap.
98.91% of the companies in the same industry are more expensive than ENOV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 25.57. ENOV is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	6.62
Fwd PE	6.3

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaply inside the industry as 92.93% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENOV indicates a somewhat cheap valuation: ENOV is cheaper than 72.83% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	55.37
EV/EBITDA	8.82

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.45

PEG (5Y)N/A

EPS Next 2Y11.17%

EPS Next 3Y11.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ENOV!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ENOVIS CORP / ENOV FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.

What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.

Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.

What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.